Induction of hyperintense signal on T2-weighted MR images correlates with infusion distribution from intracerebral convection-enhanced delivery of a tumor-targeted cytotoxin
- PMID: 17312057
- DOI: 10.2214/AJR.06.0428
Induction of hyperintense signal on T2-weighted MR images correlates with infusion distribution from intracerebral convection-enhanced delivery of a tumor-targeted cytotoxin
Abstract
Objective: Convection-enhanced delivery is a promising approach to intracerebral drug delivery in which a fluid pressure gradient is used to infuse therapeutic macromolecules through an indwelling catheter into the interstitial spaces of the brain. Our purpose was to test the hypothesis that hyperintense signal changes on T2-weighted images produced by such infusions can be used to track drug distribution.
Subjects and methods: Seven adults with recurrent malignant glioma underwent concurrent intracerebral infusions of the tumor-targeted cytotoxin cintredekin besudotox and 123I-labeled human serum albumin. The agents were administered through a total of 18 catheters among the seven patients. Adequacy of distribution of drug was determined by evidence of distribution of 123I-labeled human serum albumin on SPECT images coregistered with MR images. Qualitative analysis was performed by three blinded observers. Quantitative analysis also was performed.
Results: Infusions into 12 catheters produced intraparenchymal distribution as seen on SPECT images, but infusions into six catheters did not. At qualitative assessment of signal changes on MR images, reviewers correctly predicted which catheters would produce extraparenchymal distribution and which catheters would produce parenchymal distribution. Of the 12 infusions that produced intraparenchymal distribution, four catheters had been placed in regions of relatively normal signal intensity and produced regions of newly increased signal intensity, the volume of which highly correlated with the volume and geometry of distribution on SPECT (r2 = 0.9502). Eight infusions that produced intraparenchymal distribution were performed in regions of preexisting hyperintense signal. In these brains, additional signal changes were always produced, but quantitative correlations between areas of newly increased signal intensity and the volume and geometry of distribution on SPECT could not be established.
Conclusion: Convection-enhanced infusions frequently do not provide intraparenchymal drug distribution, and these failures can be identified with MRI soon after infusion. When infusions are performed into regions of normal signal intensity, development of hyperintense signal change strongly correlates with the volume and geometry of distribution of infusate.
Similar articles
-
Safety of intraparenchymal convection-enhanced delivery of cintredekin besudotox in early-phase studies.Neurosurg Focus. 2006 Apr 15;20(4):E15. Neurosurg Focus. 2006. PMID: 16709020 Clinical Trial.
-
Intracerebral infusate distribution by convection-enhanced delivery in humans with malignant gliomas: descriptive effects of target anatomy and catheter positioning.Neurosurgery. 2007 Feb;60(2 Suppl 1):ONS89-98; discussion ONS98-9. doi: 10.1227/01.NEU.0000249256.09289.5F. Neurosurgery. 2007. PMID: 17297371 Clinical Trial.
-
Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group.J Clin Oncol. 2007 Mar 1;25(7):837-44. doi: 10.1200/JCO.2006.08.1117. J Clin Oncol. 2007. PMID: 17327604 Clinical Trial.
-
Convection-enhanced delivery of interleukin-13 receptor-directed cytotoxin for malignant glioma therapy.Technol Cancer Res Treat. 2006 Jun;5(3):239-50. doi: 10.1177/153303460600500307. Technol Cancer Res Treat. 2006. PMID: 16700620 Review.
-
Convection enhanced drug delivery of novel therapeutic agents to malignant brain tumors.Curr Drug Deliv. 2007 Apr;4(2):169-80. doi: 10.2174/156720107780362302. Curr Drug Deliv. 2007. PMID: 17456036 Review.
Cited by
-
Automated segmentation tool for brain infusions.PLoS One. 2013 Jun 5;8(6):e64452. doi: 10.1371/journal.pone.0064452. Print 2013. PLoS One. 2013. PMID: 23755125 Free PMC article.
-
Colocalization of gadolinium-diethylene triamine pentaacetic acid with high-molecular-weight molecules after intracerebral convection-enhanced delivery in humans.Neurosurgery. 2011 Sep;69(3):668-76. doi: 10.1227/NEU.0b013e3182181ba8. Neurosurgery. 2011. PMID: 21430586 Free PMC article.
-
Imaging of Convective Drug Delivery in the Nervous System.Neurosurg Clin N Am. 2017 Oct;28(4):615-622. doi: 10.1016/j.nec.2017.05.012. Epub 2017 Aug 19. Neurosurg Clin N Am. 2017. PMID: 28917289 Free PMC article. Review.
-
IL-13Rα2-Targeted Therapy Escapees: Biologic and Therapeutic Implications.Transl Oncol. 2011 Dec;4(6):390-400. doi: 10.1593/tlo.11175. Epub 2011 Dec 1. Transl Oncol. 2011. PMID: 22191003 Free PMC article.
-
Convection-enhanced delivery of free gadolinium with the recombinant immunotoxin MR1-1.J Neurooncol. 2010 May;98(1):1-7. doi: 10.1007/s11060-009-0046-7. Epub 2009 Nov 7. J Neurooncol. 2010. PMID: 19898744 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical